PRHSX vs. FPHAX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
PRHSX vs. FPHAX - Performance Comparison
Loading graphics...
PRHSX vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -9.65% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | -2.56% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
Returns By Period
In the year-to-date period, PRHSX achieves a -9.65% return, which is significantly lower than FPHAX's -2.56% return. Both investments have delivered pretty close results over the past 10 years, with PRHSX having a 11.42% annualized return and FPHAX not far behind at 10.94%.
PRHSX
- 1D
- 0.37%
- 1M
- -9.33%
- YTD
- -9.65%
- 6M
- 18.49%
- 1Y
- 20.86%
- 3Y*
- 9.06%
- 5Y*
- 4.83%
- 10Y*
- 11.42%
FPHAX
- 1D
- 0.57%
- 1M
- -9.52%
- YTD
- -2.56%
- 6M
- 15.21%
- 1Y
- 27.23%
- 3Y*
- 16.20%
- 5Y*
- 11.88%
- 10Y*
- 10.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. FPHAX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is higher than FPHAX's 0.75% expense ratio.
Return for Risk
PRHSX vs. FPHAX — Risk / Return Rank
PRHSX
FPHAX
PRHSX vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | 1.14 | -0.22 |
Sortino ratioReturn per unit of downside risk | 1.60 | 1.61 | -0.01 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.21 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | 2.05 | -0.53 |
Martin ratioReturn relative to average drawdown | 4.47 | 5.99 | -1.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | 1.14 | -0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.67 | -0.40 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | 0.62 | -0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.52 | +0.11 |
Correlation
The correlation between PRHSX and FPHAX is 0.84, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PRHSX vs. FPHAX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 26.63%, more than FPHAX's 5.83% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 26.63% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.83% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
PRHSX vs. FPHAX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for PRHSX and FPHAX.
Loading graphics...
Drawdown Indicators
| PRHSX | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -38.26% | -4.70% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -11.00% | -1.81% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -28.82% | +1.21% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -28.82% | -0.15% |
Current DrawdownCurrent decline from peak | -12.49% | -9.82% | -2.67% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -9.21% | +0.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.36% | 4.35% | +0.01% |
Volatility
PRHSX vs. FPHAX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 5.30%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 6.10%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.30% | 6.10% | -0.80% |
Volatility (6M)Calculated over the trailing 6-month period | 15.97% | 14.17% | +1.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.33% | 23.39% | -1.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.01% | 17.69% | +0.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.65% | 17.78% | +1.87% |